DONGGUAN, China, Feb. 2, 2024 – On February 1, 2024, Fapon, a global leading life science company, and Bio Farma, a state-owned pharmaceutical holding company in Indonesia specializing in vaccines, life science products, and other pharmaceuticals, signed a memorandum of understanding to formalize their commitment to strengthening medical innovations in Indonesia. In doing so, the memorandum will further solidify Fapon’s global ecosystem for diagnostics and medical treatment. Jielun ZHU, Chief Financial Officer and Chief Investment Officer of Fapon, I.G.N. Suharta Wijaya, Finance and Risk Management Director of Bio Farma and Sri Harsi Teteki, Medical, Institutional and Governance Relations Director of Bio Farma attended the official signing ceremony.
The partnership between Fapon and Bio Farma focuses on developing biological medicines and technologies, medical devices, and IVD solutions with an emphasis on healthcare localization. The goal is to foster a synergistic collaboration between the two companies, drive medical innovation and technology transfer, and boost the development of healthcare industry in Indonesia.
During the official signing ceremony, Sri Harsi Teteki, Medical, Institutional and Governance Relations Director of Bio Farma, stated that the partnership with Fapon will leverage the strengths of both companies to innovate medical technologies and ultimately contribute to the enhancement of healthcare services in the country.
Jielun ZHU, Chief Financial Officer and Chief Investment Officer of Fapon, reflected that Fapon is dedicated to deploying its expertise and technologies to work with Bio Farma, and advancing medical innovations to address the healthcare needs in Indonesia.
With more than 20 years of experience in the medical industry, Fapon has earned the trust of over 2500 business partners across 68 countries worldwide. Rooted in the Indonesian market for years, Fapon has demonstrated its commitment to supporting the local healthcare development by establishing a local office and forging strategic partnerships with local companies.
Looking ahead, Fapon is committed to strengthening its cooperation with Bio Farma to drive the development of medical innovations, thereby advancing the quality of healthcare services in Indonesia.
